Search
for
Sort by
Research 91–120 of 1000+
- Tyrosinase inhibition due to interaction of homocyst(e)ine with copper: the mechanism for reversible hypopigmentation in homocystinuria due to cystathionine beta-synthase deficiency.
- 014 Tyrosine Kinase 2 Inhibition Ameliorates the Phenotype of Lesional Alopecia Areata Scalp Skin Ex Vivo, and Reverses the Induction of Human Alopecia Areata in a Humanized Mouse Model
- Desmodesmus pannonicus Water Extract Inhibits Melanin Synthesis and Promotes Wound Healing
- Molecular Targets in Modern Cosmetic Science
- 518 Nutrient and stress sensing as novel physiological regulator of human hair pigmentation and greying: Role of mTORC1 activity
- Spontaneous hair hyperpigmentation in response to vitamin intake in pregnancy—A clue for homocystinuria
- The multiple uses of azelaic acid in dermatology: mechanism of action, preparations, and potential therapeutic applications
- 녹차의 에피갈로카테킨 갈레이트(EGCG) 활성기전이 신체 내·외적으로 미치는 영향에 대한 고찰
- MicroRNA control of signal transduction
- 3D organotypic skin models recapitulate autoantibody-driven pemphigus pathomechanisms and targeted therapeutic response
- A Case of Hair Change and Acneiform Eruption Induced by ZD1839 (Iressa$^{(R)}$)
- Non-small cell lung carcinoma spheroid models in agarose microwells for drug response studies
- Sorting Out the Seeming Increase in Lung Cancer in Women Who Have Never Smoked
- Contemporary drug synthesis
- Improving the treatment of bacterial infections caused by multidrug-resistant bacteria through drug repositioning
- Premature hair graying: a multifaceted phenomenon
- Drug Repurposing Patent Applications April–June 2021
- Localizing the ROS Signal
- P718 Observational real-world evidence on the efficacy and safety of Janus Kinase inhibitors (JAKi) in the treatment of moderate to severe Active Ulcerative Colitis (UC)
- Janus Kinase inhibitors in dermatology: a review
- The Role of Janus Kinase Inhibitors in Dermatology
- Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors
- MARIO LACOUTURE: How Do I Treat a Patient with Dermatologic Toxicities to EGFR Inhibitors?
- Sulfatase inhibitors: a patent review
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- Paracrine Secreted Frizzled-Related Protein 4 Inhibits Melanocytes Differentiation in Hair Follicle
- Prevention of Chemotherapy-Induced Alopecia in Rats by CDK Inhibitors
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?